Healthcare Analytical Testing Services Market By Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030

1 INTRODUCTION 38 1.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 MARKET SCOPE 39 1.3.1 MARKETS & REGIONS COVERED 39 1.3.2 REGIONS COVERED 40 1.3.3 INCLUSIONS & EXCLUSIONS 40 1.3.4 YEARS CONSIDERED 41 1.3.5 CURRENCY CONSIDERED 41 1.4 LIMITATIONS 41 1.4.1 METHODOLOGY-RELATED LIMITATIONS 42 1.4.2 SCOPE-RELATED LIMITATIONS 42 1.5 MARKET STAKEHOLDERS 42 1.6 SUMMARY OF CHANGES 43 2 RESEARCH METHODOLOGY 44 2.1 RESEARCH DATA 44 2.2 RESEARCH METHODOLOGY STEPS 44 2.2.1 SECONDARY DATA 45 2.2.1.1 List of secondary sources 46 2.2.1.2 Key data from secondary sources 47 2.2.2 PRIMARY DATA 47 2.2.2.1 Key data from primary sources 48 2.2.2.2 Insights from primary experts 49 2.3 MARKET ESTIMATION METHODOLOGY 50 2.3.1 PRIMARY RESEARCH VALIDATION 57 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 58 2.5 RESEARCH ASSUMPTIONS 59 2.5.1 STUDY ASSUMPTIONS 59 2.6 RESEARCH LIMITATIONS 60 2.7 RISK ASSESSMENT 60 3 EXECUTIVE SUMMARY 61   4 PREMIUM INSIGHTS 66 4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW 66 4.2 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE & COUNTRY (2024) 67 4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68 4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL MIX, 2023–2030 (USD MILLION) 69 5 MARKET OVERVIEW 70 5.1 INTRODUCTION 70 5.2 MARKET DYNAMICS 70 5.2.1 DRIVERS 71 5.2.1.1 Stringent regulatory guidelines 71 5.2.1.2 Growing focus on analytical testing of biologics & biosimilars 72 5.2.1.3 Increasing outsourcing of analytical testing services by pharmaceutical & medical device companies 73 5.2.1.4 Rising number of clinical trials 73 5.2.1.5 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry 74 5.2.1.6 Rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing 75 5.2.2 RESTRAINTS 76 5.2.2.1 Increasing pressure on market players due to rising costs and market competition 76 5.2.3 OPPORTUNITIES 77 5.2.3.1 Adoption of new techniques and technologies 77 5.2.3.2 Growing focus on emerging economies 78 5.2.4 CHALLENGES 79 5.2.4.1 Shortage of skilled professionals 79 5.2.4.2 Specific requirements for innovative formulations and medical devices 79 5.2.4.3 Challenges associated with ensuring bioanalytical testing sensitivity 80 5.3 ECOSYSTEM ANALYSIS 80 5.4 REGULATORY SCENARIO 82 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 82 5.4.2 REGULATORY TRENDS 84 5.4.3 NORTH AMERICA 86 5.4.4 EUROPE 86 5.4.5 ASIA PACIFIC 87 5.5 VALUE CHAIN ANALYSIS 88 5.5.1 SAMPLE MANAGEMENT & PREPARATION 88 5.5.2 ANALYTICAL TESTING PROCEDURES 88 5.5.3 DATA ANALYTICS & INTEGRATION 88 5.5.4 QUALITY ASSURANCE & CONTROL 88 5.5.5 CLIENT COMMUNICATION & SERVICE DELIVERY 89 5.6 CASE STUDY ANALYSIS 89 5.6.1 CASE STUDY 1: UNLOCKING POTENTIAL OF BIOPHARMACEUTICAL DEVELOPMENT THROUGH ANALYTICAL TESTING OUTSOURCING 89 5.6.2 CASE STUDY 2: REVOLUTIONIZING PHARMACEUTICAL TESTING 90 5.7 PORTER’S FIVE FORCES ANALYSIS 90 5.7.1 THREAT OF NEW ENTRANTS 91 5.7.2 BARGAINING POWER OF SUPPLIERS 92 5.7.3 INTENSITY OF COMPETITIVE RIVALRY 92 5.7.4 BARGAINING POWER OF BUYERS 92 5.7.5 THREAT OF SUBSTITUTES 92 5.8 KEY STAKEHOLDERS & BUYING CRITERIA 93 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 93 5.8.2 KEY BUYING CRITERIA 94 5.9 TECHNOLOGY ANALYSIS 95 5.9.1 KEY TECHNOLOGIES 95 5.9.1.1 Chromatography 95 5.9.1.2 Mass spectrometry (MS) 95 5.9.1.3 Spectroscopy 96 5.9.2 COMPLEMENTARY TECHNOLOGIES 96 5.9.2.1 Laboratory Information Management Systems (LIMS) 96 5.9.2.2 Automation & robotics 96 5.9.2.3 AI/ML in data analytics 96 5.9.3 ADJACENT TECHNOLOGIES 97 5.9.3.1 Single-use bioreactors 97 5.9.3.2 mRNA technology 97 5.9.3.3 Next-generation Sequencing (NGS) 97 5.10 KEY CONFERENCES & EVENTS, 2024─2025 98 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99 5.12 INVESTMENT & FUNDING SCENARIO 99 5.13 UNMET NEEDS/END-USER EXPECTATIONS 101 5.14 IMPACT OF AI/GENERATIVE AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 102 5.15 TRUMP TARIFF IMPACT ON HEALTHCARE ANALYTICAL TESTING MARKET 103 5.15.1 INTRODUCTION 103 5.15.2 KEY TARIFF RATES 105 5.15.3 PRICE IMPACT ANALYSIS 106 5.15.4 KEY IMPACT ON VARIOUS REGIONS 107 5.15.4.1 North America 107 5.15.4.2 Europe 107 5.15.4.3 Asia Pacific 108 6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE 109 6.1 INTRODUCTION 110 6.2 BIOANALYTICAL TESTING SERVICES 110 6.2.1 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES 112 6.2.1.1 Essential role in drug individualized dosing and therapeutic monitoring to drive market 112 6.2.2 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES 113 6.2.2.1 Increasing requirement for drug safety approvals to fuel uptake 113 6.2.3 BIOMARKER TESTING SERVICES SERVICES 114 6.2.3.1 Growing preference for personalized medicine to fuel market 114 6.2.4 BIOASSAY TESTING SERVICES 115 6.2.4.1 Growing adoption of high-content screening for cytotoxicity testing to boost demand 115 6.2.5 OTHER BIOANALYTICAL TESTING SERVICES 116 6.3 PHYSICAL CHARACTERIZATION SERVICES 117 6.3.1 LASER PARTICLE SIZE ANALYSIS SERVICES 118 6.3.1.1 Growing importance of pharmaceutical dosage manufacturing to drive market 118 6.3.2 THERMAL ANALYSIS SERVICES 119 6.3.2.1 Advancements in thermal analysis techniques to support market growth 119 6.3.3 OPTICAL CHARACTERIZATION SERVICES 120 6.3.3.1 Increasing complexities of biological structures to boost demand 120 6.3.4 SURFACE AREA ANALYSIS SERVICES 121 6.3.4.1 Growing focus on streamlining drug development processes to fuel uptake 121 6.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES 122 6.4 METHOD DEVELOPMENT & VALIDATION SERVICES 123 6.4.1 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES 125 6.4.1.1 Adoption of parenterally administered drugs and biologics products to drive market 125 6.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES 126 6.4.2.1 Increasing emphasis on impurity testing to boost market 126 6.4.3 STABILITY-INDICATING METHOD VALIDATION SERVICES 127 6.4.3.1 Growing need to ensure safety & efficacy of drugs to drive market 127 6.4.4 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES 127 6.4.4.1 Focus on contamination reduction to fuel market 127 6.4.5 ANALYTICAL STANDARD CHARACTERIZATION SERVICES 128 6.4.5.1 Assessment of quantitative & qualitative accuracy to fuel uptake 128 6.4.6 TECHNICAL CONSULTING SERVICES 129 6.4.6.1 Stringent regulatory compliance to boost demand 129 6.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES 130 6.5 RAW MATERIAL TESTING SERVICES 131 6.5.1 COMPLETE COMPENDIAL TESTING SERVICES 132 6.5.1.1 Need to determine efficacy & safety of therapeutic products to drive market 132 6.5.2 CONTAINER TESTING SERVICES 133 6.5.2.1 Optimization of sealing & evaluation of temperature impact to fuel uptake 133 6.5.3 HEAVY METAL TESTING SERVICES 134 6.5.3.1 Uptake of specialized equipment to support market growth 134 6.5.4 WATER CONTENT ANALYSIS SERVICES 135 6.5.4.1 Adequate moisture content analysis to fuel market 135 6.5.5 OTHER RAW MATERIAL TESTING SERVICES 136 6.6 BATCH-RELEASE TESTING SERVICES 137 6.6.1 DISSOLUTION TESTING SERVICES 138 6.6.1.1 Wide usage across formulation development & manufacturing applications to drive market 138 6.6.2 ELEMENTAL IMPURITY TESTING SERVICES 139 6.6.2.1 Rising need to minimize cost of in-house analysis to fuel market 139 6.6.3 DISINTEGRATION TESTING SERVICES 140 6.6.3.1 Ability to ensure batch-to-batch consistency of pharmaceutical dosage forms to fuel market 140 6.6.4 HARDNESS TESTING SERVICES 142 6.6.4.1 Measurement of tablet quality to support market growth 142 6.6.5 FRIABILITY TESTING SERVICES 143 6.6.5.1 Resistance measurement of tablets & granules to fuel market 143 6.6.6 OTHER BATCH-RELEASE TESTING SERVICES 143 6.7 STABILITY TESTING SERVICES 144 6.7.1 DRUG SUBSTANCE STABILITY TESTING SERVICES 145 6.7.1.1 Evidence testing on quality of pharmaceutical stability to fuel market 145 6.7.2 FORMULATION EVALUATION STABILITY TESTING SERVICES 146 6.7.2.1 Analysis of shelf life to fuel adoption 146 6.7.3 ACCELERATED STABILITY TESTING SERVICES 147 6.7.3.1 High stress conditions to provide enhanced results 147 6.7.4 PHOTOSTABILITY TESTING SERVICES 148 6.7.4.1 Systemic approach for ICH guideline adherence to propel market 148 6.7.5 FORCED DEGRADATION TESTING SERVICES 149 6.7.5.1 Rising need for comprehensive stability testing to drive market 149 6.7.6 OTHER STABILITY TESTING SERVICES 150 6.8 MICROBIAL TESTING SERVICES 150 6.8.1 MICROBIAL LIMIT TESTING SERVICES 151 6.8.1.1 Microbial quality efficacy testing to boost demand 151 6.8.2 VIROLOGY TESTING SERVICES 153 6.8.2.1 Increasing outbreaks of viral diseases to drive market 153 6.8.3 STERILITY TESTING SERVICES 154 6.8.3.1 Rising development of parenteral preparations and immunological products to drive market 154 6.8.4 ENDOTOXIN TESTING SERVICES 155 6.8.4.1 Endoxin-free testing to fuel market 155 6.8.5 PRESERVATIVE EFFICACY TESTING SERVICES 156 6.8.5.1 PET testing for toxicity to fuel uptake 156 6.8.6 OTHER MICROBIAL TESTING SERVICES 156 6.9 ENVIRONMENTAL MONITORING SERVICES 157 6.9.1 AIR TESTING SERVICES 158 6.9.1.1 Air contamination testing for quality checks to fuel market 158 6.9.2 WASTEWATER/ETP TESTING SERVICES 160 6.9.2.1 Need to minimize water contamination to fuel market 160 6.9.3 OTHER ENVIRONMENTAL MONITORING TESTING SERVICES 161 6.10 GENOMIC TESTING SERVICES 162 6.10.1 DETECTION OF DISEASE MECHANISMS AND TREATMENT RESPONSES TO PROPEL MARKET 162 6.11 OTHER ANALYTICAL TESTING SERVICES 163 7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER 164 7.1 INTRODUCTION 165 7.2 PHARMACEUTICAL COMPANIES 165 7.2.1 GROWTH IN PHARMACEUTICAL INDUSTRY TO PROPEL MARKET 165 7.3 BIOPHARMACEUTICAL COMPANIES 167 7.3.1 INCREASING R&D INVESTMENTS TO FUEL MARKET 167 7.4 MEDICAL DEVICE COMPANIES 168 7.4.1 STRINGENT PRODUCT COMMERCIALIZATION GUIDELINES TO DRIVE MARKET 168 7.5 HOSPITALS & CLINICS 169 7.5.1 INCREASING INCIDENCE OF CHRONIC DISEASES TO BOOST DEMAND 169 7.6 FORENSIC LABS 170 7.6.1 RISING UTILIZATION OF ANALYTICAL TESTING TO FUEL MARKET 170 7.7 COSMETIC & NUTRACEUTICAL COMPANIES 171 7.7.1 RISING FOCUS ON QUALITY CONTROL TESTING TO FUEL UPTAKE 171 7.8 OTHER END USERS 172 8 HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION 174 8.1 INTRODUCTION 175 8.2 NORTH AMERICA 175 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 176 8.2.2 US 183 8.2.2.1 High number of pre-registration drugs in pipeline to drive market 183 8.2.3 CANADA 188 8.2.3.1 Presence of well-established CROs to support market growth 188 8.3 EUROPE 193 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 194 8.3.2 GERMANY 199 8.3.2.1 Government support and flexible labor laws to boost demand 199 8.3.3 FRANCE 205 8.3.3.1 Favorable government regulations to drive market 205 8.3.4 UK 210 8.3.4.1 Increasing outsourcing of biopharmaceutical R&D to drive market 210 8.3.5 ITALY 215 8.3.5.1 Availability of drug discovery funding investments to fuel market 215 8.3.6 SWITZERLAND 220 8.3.6.1 High production of pharma drugs to fuel uptake 220 8.3.7 SPAIN 225 8.3.7.1 Rising number of clinical trials to boost demand 225 8.3.8 REST OF EUROPE 230 8.4 ASIA PACIFIC 235 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 236 8.4.2 JAPAN 243 8.4.2.1 Expanding geriatric population and increasing incidence of chronic diseases to propel market 243 8.4.3 CHINA 248 8.4.3.1 Increasing incidence of infectious diseases to boost demand 248 8.4.4 INDIA 253 8.4.4.1 Growing focus on establishment of genomic testing centers to drive market 253 8.4.5 AUSTRALIA 258 8.4.5.1 Large number of research institutes to support market uptake 258 8.4.6 SOUTH KOREA 263 8.4.6.1 Launch of innovative pharma drugs to boost demand 263 8.4.7 REST OF ASIA PACIFIC 268 8.5 LATIN AMERICA 273 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 273 8.5.2 BRAZIL 279 8.5.2.1 Rising adoption of emerging medical technologies to drive market 279 8.5.3 MEXICO 284 8.5.3.1 Favorable regulatory environment for API products to fuel market 284 8.5.4 REST OF LATIN AMERICA 289 8.6 MIDDLE EAST & AFRICA 294 8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 295 8.6.2 GCC COUNTRIES 300 8.6.2.1 Improvements in healthcare infrastructure to boost demand 300 8.6.3 REST OF MIDDLE EAST & AFRICA 305 9 COMPETITIVE LANDSCAPE 310 9.1 OVERVIEW 310 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 310 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 310 9.3 REVENUE ANALYSIS, 2020−2024 312 9.4 MARKET SHARE ANALYSIS, 2024 313 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 315 9.5.1 STARS 316 9.5.2 EMERGING LEADERS 316 9.5.3 PERVASIVE PLAYERS 316 9.5.4 PARTICIPANTS 316 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 318 9.5.5.1 Company footprint 318 9.5.5.2 Region footprint 319 9.5.5.3 Type footprint 320 9.5.5.4 End-user footprint 321 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 322 9.6.1 PROGRESSIVE COMPANIES 322 9.6.2 RESPONSIVE COMPANIES 322 9.6.3 DYNAMIC COMPANIES 322 9.6.4 STARTING BLOCKS 322 9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 324 9.6.5.1 Detailed list of startups/SMEs 324 9.6.5.2 Competitive benchmarking of emerging players/startups 325 9.7 COMPANY VALUATION & FINANCIAL METRICS 327 9.7.1 FINANCIAL METRICS 327 9.7.2 COMPANY VALUATION 327 9.8 BRAND/SERVICE COMPARISON 328 9.8.1 BRAND/SERVICE COMPARATIVE ANALYSIS 328 9.9 COMPETITIVE SCENARIO 329 9.9.1 SERVICE LAUNCHES 329 9.9.2 DEALS 330 9.9.3 EXPANSIONS 331 10 COMPANY PROFILES 333 10.1 KEY PLAYERS 333 10.1.1 EUROFINS SCIENTIFIC SE 333 10.1.1.1 Business overview 333 10.1.1.2 Services offered 334 10.1.1.3 Recent developments 336 10.1.1.3.1 Deals 336 10.1.1.3.2 Expansions 337 10.1.1.4 MnM view 337 10.1.1.4.1 Key strengths 337 10.1.1.4.2 Strategic choices 338 10.1.1.4.3 Weaknesses & competitive threats 338 10.1.2 LABCORP HOLDINGS INC. 339 10.1.2.1 Business overview 339 10.1.2.2 Services offered 340 10.1.2.3 Recent developments 341 10.1.2.3.1 Services launches 341 10.1.2.3.2 Deals 341 10.1.2.3.3 Expansions 342 10.1.2.4 MnM view 343 10.1.2.4.1 Key strengths 343 10.1.2.4.2 Strategic choices 343 10.1.2.4.3 Weaknesses & competitive threats 343 10.1.3 INTERTEK GROUP PLC 344 10.1.3.1 Business overview 344 10.1.3.2 Services offered 345 10.1.3.3 Recent developments 349 10.1.3.3.1 Deals 349 10.1.3.3.2 Expansions 349 10.1.3.4 MnM view 350 10.1.3.4.1 Key strengths 350 10.1.3.4.2 Strategic choices 350 10.1.3.4.3 Weaknesses & competitive threats 350 10.1.4 ICON PLC 351 10.1.4.1 Business overview 351 10.1.4.2 Services offered 352 10.1.4.3 Recent developments 353 10.1.4.3.1 Deals 353 10.1.4.4 MnM view 354 10.1.4.4.1 Key strengths 354 10.1.4.4.2 Strategic choices 354 10.1.4.4.3 Weaknesses & competitive threats 354 10.1.5 IQVIA INC. 355 10.1.5.1 Business overview 355 10.1.5.2 Services offered 356 10.1.5.3 Recent developments 357 10.1.5.3.1 Expansions 357 10.1.5.3.2 Other developments 358 10.1.5.4 MnM view 358 10.1.5.4.1 Key strengths 358 10.1.5.4.2 Strategic choices 358 10.1.5.4.3 Weaknesses & competitive threats 358 10.1.6 WUXI APPTEC CO., LTD. 359 10.1.6.1 Business overview 359 10.1.6.2 Services offered 360 10.1.6.3 Recent developments 361 10.1.6.3.1 Service launches 361 10.1.6.3.2 Deals 362 10.1.6.3.3 Expansions 362 10.1.7 CHARLES RIVER LABORATORIES 363 10.1.7.1 Business overview 363 10.1.7.2 Services offered 364 10.1.7.3 Recent developments 365 10.1.7.3.1 Service launches & approvals 365 10.1.7.3.2 Deals 366 10.1.7.3.3 Expansions 367 10.1.8 SGS SA 368 10.1.8.1 Business overview 368 10.1.8.2 Services offered 369 10.1.8.3 Recent developments 371 10.1.8.3.1 Service launches 371 10.1.8.3.2 Deals 371 10.1.8.3.3 Expansions 372 10.1.8.3.4 Other developments 373 10.1.9 THERMO FISHER SCIENTIFIC INC. 374 10.1.9.1 Business overview 374 10.1.9.2 Services offered 375 10.1.9.3 Recent developments 376 10.1.9.3.1 Deals 376 10.1.9.3.2 Expansions 377 10.1.10 MEDPACE HOLDINGS, INC. 378 10.1.10.1 Business overview 378 10.1.10.2 Services offered 379 10.1.10.3 Recent developments 380 10.1.10.3.1 Deals 380 10.1.10.3.2 Expansions 380 10.1.11 SARTORIUS AG 381 10.1.11.1 Business overview 381 10.1.11.2 Services offered 382 10.1.11.3 Recent developments 383 10.1.11.3.1 Deals 383 10.1.11.3.2 Expansions 383 10.1.12 MERCK KGAA 384 10.1.12.1 Business overview 384 10.1.12.2 Services offered 385 10.1.12.3 Recent developments 386 10.1.12.3.1 Service launches 386 10.1.12.3.2 Deals 386 10.1.12.3.3 Expansions 387 10.1.12.3.4 Other developments 387 10.1.13 SOURCE BIOSCIENCE (SUBSIDIARY OF SOURCEBIO INTERNATIONAL PLC) 389 10.1.13.1 Business overview 389 10.1.13.2 Services offered 390 10.1.13.3 Recent developments 390 10.1.13.3.1 Service launches 390 10.1.13.3.2 Expansions 391 10.1.14 ALS 392 10.1.14.1 Business overview 392 10.1.14.2 Services offered 393 10.1.14.3 Recent developments 394 10.1.14.3.1 Deals 394 10.1.15 FRONTAGE LABORATORIES, INC. 395 10.1.15.1 Business overview 395 10.1.15.2 Services offered 396 10.1.15.3 Recent developments 398 10.1.15.3.1 Deals 398 10.1.15.3.2 Expansions 398 10.1.16 STERIS PLC 399 10.1.16.1 Business overview 399 10.1.16.2 Services offered 400 10.1.16.3 Recent developments 401 10.1.16.3.1 Service launches 401 10.1.16.3.2 Expansions 401 10.1.16.3.3 Other developments 402 10.1.17 ELEMENT MATERIALS TECHNOLOGY 403 10.1.17.1 Business overview 403 10.1.17.2 Services offered 403 10.1.17.3 Recent developments 404 10.1.17.3.1 Service launches 404 10.1.17.3.2 Deals 404 10.1.17.3.3 Expansions 405 10.1.17.3.4 Other developments 406   10.1.18 PACE ANALYTICAL SERVICES 407 10.1.18.1 Business overview 407 10.1.18.2 Services offered 407 10.1.18.3 Recent developments 409 10.1.18.3.1 Deals 409 10.1.18.3.2 Expansions 411 10.1.19 ALMAC GROUP 412 10.1.19.1 Business overview 412 10.1.19.2 Services offered 412 10.1.19.3 Recent developments 413 10.1.19.3.1 Service approvals 413 10.1.19.3.2 Deals 413 10.1.19.3.3 Expansions 413 10.1.20 PHARMARON BEIJING CO., LTD. 415 10.1.20.1 Business overview 415 10.1.20.2 Services offered 415 10.1.20.3 Recent developments 416 10.1.20.3.1 Deals 416 10.2 OTHER PLAYERS 417 10.2.1 SYNEOS HEALTH 417 10.2.2 PAREXEL INTERNATIONAL (MA) CORPORATION 418 10.2.3 LGC LIMITED 419 10.2.4 CELERION 420 10.2.5 BIOAGILYTIX 421 10.2.6 ALCAMI CORPORATION 422 10.2.7 SAMSUNG BIOLOGICS 423 10.2.8 CURIA GLOBAL, INC. 424 10.2.9 BA SCIENCES 425 10.2.10 AVANCE BIOSCIENCES 426 11 APPENDIX 427 11.1 DISCUSSION GUIDE 427 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 432 11.3 CUSTOMIZATION OPTIONS 434 11.4 RELATED REPORTS 434 11.5 AUTHOR DETAILS 435

TABLE 1 INCLUSIONS & EXCLUSIONS 40 TABLE 2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RISK ASSESSMENT ANALYSIS 60 TABLE 3 PATENT EXPIRY OF BEST-SELLING BIOLOGICS 72 TABLE 4 IMPACT ANALYSIS: DRIVERS 76 TABLE 5 IMPACT ANALYSIS: RESTRAINTS 77 TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES 78 TABLE 7 IMPACT ANALYSIS: CHALLENGES 80 TABLE 8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM 81 TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS 84 TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES 85 TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES 86 TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES 87 TABLE 18 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 90 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 94 TABLE 20 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY RANK 95 TABLE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF LEADING CONFERENCES & EVENTS 98 TABLE 22 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CURRENT UNMET NEEDS/END-USER EXPECTATIONS 101 TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES 105 TABLE 24 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 111 TABLE 26 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 27 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES MARKET, BY REGION 112 TABLE 28 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 29 BIOMARKER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 30 BIOASSAY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 31 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 32 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 33 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 34 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 35 THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 36 OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 37 SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 38 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 39 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 40 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 41 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 42 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 43 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 44 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 45 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 46 TECHNICAL CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 47 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 48 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 132 TABLE 49 RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 50 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 51 CONTAINER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 52 HEAVY METAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 53 WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 54 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 55 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 56 BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 57 DISSOLUTION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 58 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 59 BREAKDOWN OF DISINTEGRATION METHODS & IMMERSION MEDIA 141 TABLE 60 DISINTEGRATION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 61 HARDNESS TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 62 FRIABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 63 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 64 STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 65 STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 66 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 67 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 68 ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 69 PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 70 FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 71 OTHER STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 72 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 73 MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 74 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING 152 TABLE 75 MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 76 VIROLOGY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 77 STERILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 78 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 79 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 80 OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 81 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 82 ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 83 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR 159 TABLE 84 AIR TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 85 STANDARDS FOR WASTEWATER QUALITY 160 TABLE 86 WASTEWATER/ETP SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 87 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 88 GENOMIC TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 89 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 90 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 91 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 92 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 93 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 94 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 95 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 96 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 172 TABLE 97 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 98 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 99 NORTH AMERICA: KEY MACROINDICATORS 176 TABLE 100 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 101 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 102 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 103 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 104 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 105 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 106 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 107 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 108 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 109 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 110 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 111 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 112 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 113 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 114 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 115 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 116 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 117 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 118 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 119 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 120 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 121 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 122 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 123 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 124 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 125 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 126 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 127 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 128 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 129 EUROPE: KEY MACROINDICATORS 194 TABLE 130 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 131 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 132 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 133 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 134 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 135 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 136 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 137 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 138 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 139 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 140 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 141 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 142 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 143 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 144 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 145 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 146 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 147 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 148 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 149 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 150 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 151 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 152 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 153 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 154 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 155 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 156 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 157 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 158 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 159 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 160 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 161 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 162 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 163 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 164 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 165 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 166 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 167 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 168 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 169 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 170 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 171 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 172 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 173 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 174 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 175 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 176 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 177 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 178 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 179 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 180 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 181 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 182 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 183 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 184 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 185 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 186 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 187 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 188 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 189 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 190 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 191 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 192 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 193 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 194 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 195 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 196 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 197 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 198 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 199 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 200 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 201 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 202 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 203 REST OF EUR0PE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 204 ASIA PACIFIC: MACROECONOMIC INDICATORS 236 TABLE 205 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 206 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 207 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 208 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 209 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 210 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 211 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 212 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 213 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 214 ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 215 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 216 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 217 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 218 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 219 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 220 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 221 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 222 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 223 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 224 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 225 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 226 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 227 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 228 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 229 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 230 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 231 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 232 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 233 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 234 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 235 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 236 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 237 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 238 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 239 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 240 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 241 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 242 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 243 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 244 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 245 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 246 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 247 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 248 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 249 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 250 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 251 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 252 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 253 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 254 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 255 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 256 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 257 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 258 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 259 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 260 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 261 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 262 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 263 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 264 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 265 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 266 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 267 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 268 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 269 REST OF ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 270 LATIN AMERICA: KEY MACROINDICATORS 274 TABLE 271 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 272 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 273 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 274 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 275 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 276 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 277 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 278 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 279 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 280 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 281 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 279 TABLE 282 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 283 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 284 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 285 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 286 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 287 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 288 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 289 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 290 BRAZIL: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 291 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 292 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 293 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 294 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 295 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 296 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 297 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 298 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 299 MEXICO: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 300 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 301 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 302 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 303 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 304 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 305 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 306 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 307 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 308 REST OF LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 309 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 295 TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 295 TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 312 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 313 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 314 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 315 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 316 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 317 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 318 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 319 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 320 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 300 TABLE 321 GCC COUNTRIES: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 322 GCC COUNTRIES: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 323 GCC COUNTRIES: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 324 GCC COUNTRIES: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 325 GCC COUNTRIES: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 326 GCC COUNTRIES: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 327 GCC COUNTRIES: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 328 GCC COUNTRIES: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 329 GCC COUNTRIES: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 330 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 331 REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 332 REST OF MIDDLE EAST & AFRICA: BUBIOANAZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 333 REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 334 REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 335 REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 336 REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 337 REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 338 REST OF MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 339 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 310 TABLE 340 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION 314 TABLE 341 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGION FOOTPRINT 319 TABLE 342 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: TYPE FOOTPRINT 320 TABLE 343 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT 321 TABLE 344 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF STARTUPS/SMES 324 TABLE 345 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS 325 TABLE 346 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2021–MAY 2025 329 TABLE 347 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEALS, JANUARY 2021– JUNE 2025 330 TABLE 348 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: EXPANSIONS, JANUARY 2021– JUNE 2025 331 TABLE 349 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW 333 TABLE 350 EUROFINS SCIENTIFIC SE: SERVICES OFFERED 334 TABLE 351 EUROFINS SCIENTIFIC SE: DEALS, JANUARY 2021–JUNE 2025 336 TABLE 352 EUROFINS SCIENTIFIC SE: EXPANSIONS, JANUARY 2021–JUNE 2025 337 TABLE 353 LABCORP HOLDINGS INC.: COMPANY OVERVIEW 339 TABLE 354 LABCORP HOLDINGS INC.: SERVICES OFFERED 340 TABLE 355 LABCORP HOLDINGS INC.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 341 TABLE 356 LABCORP HOLDINGS INC.: DEALS, JANUARY 2021–JUNE 2025 341 TABLE 357 LABCORP HOLDINGS INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 342 TABLE 358 INTERTEK GROUP PLC: COMPANY OVERVIEW 344 TABLE 359 INTERTEK GROUP PLC: SERVICES OFFERED 345 TABLE 360 INTERTEK GROUP PLC: DEALS, JANUARY 2021–JUNE 2025 349 TABLE 361 INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 349 TABLE 362 ICON PLC: COMPANY OVERVIEW 351 TABLE 363 ICON PLC: SERVICES OFFERED 352 TABLE 364 ICON PLC: DEALS, JANUARY 2021–JUNE 2025 353 TABLE 365 IQVIA INC.: COMPANY OVERVIEW 355 TABLE 366 IQVIA HOLDINGS INC.: SERVICES OFFERED 356 TABLE 367 IQVIA INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 357 TABLE 368 IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 358 TABLE 369 WUXI APPTEC CO., LTD.: COMPANY OVERVIEW 359 TABLE 370 WUXI APPTEC CO., LTD.: SERVICES OFFERED 360 TABLE 371 WUXI APPTEC CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 361 TABLE 372 WUXI APPTEC CO., LTD.: DEALS, JANUARY 2021–JUNE 2025 362 TABLE 373 WUXI APPTEC CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2025 362 TABLE 374 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 363 TABLE 375 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICES OFFERED 364 TABLE 376 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2025 365 TABLE 377 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–JUNE 2025 366 TABLE 378 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021–JUNE 2025 367 TABLE 379 SGS SA: COMPANY OVERVIEW 368 TABLE 380 SGS SA: SERVICES OFFERED 369 TABLE 381 SGS SA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 371 TABLE 382 SGS SA: DEALS, JANUARY 2021–JUNE 2025 371 TABLE 383 SGS SA: EXPANSIONS, JANUARY 2021–JUNE 2025 372 TABLE 384 SGS SA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 373 TABLE 385 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 374 TABLE 386 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED 375 TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2025 376 TABLE 388 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 377 TABLE 389 MEDPACE HOLDINGS, INC.: COMPANY OVERVIEW 378 TABLE 390 MEDPACE HOLDINGS, INC.: SERVICES OFFERED 379 TABLE 391 MEDPACE HOLDINGS, INC.: DEALS, JANUARY 2021–JUNE 2025 380 TABLE 392 MEDPACE HOLDINGS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 380 TABLE 393 SARTORIUS AG: COMPANY OVERVIEW 381 TABLE 394 SARTORIUS AG: SERVICES OFFERED 382 TABLE 395 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2025 383 TABLE 396 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2025 383 TABLE 397 MERCK KGAA: COMPANY OVERVIEW 384 TABLE 398 MERCK KGAA: SERVICES OFFERED 385 TABLE 399 MERCK KGAA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 386 TABLE 400 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2025 386 TABLE 401 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2025 387 TABLE 402 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 387 TABLE 403 SOURCEBIO INTERNATIONAL PLC: COMPANY OVERVIEW 389 TABLE 404 SOURCEBIO INTERNATIONAL PLC: SERVICES OFFERED 390 TABLE 405 SOURCEBIO INTERNATIONAL PLC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 390 TABLE 406 SOURCEBIO INTERNATIONAL PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 391 TABLE 407 ALS: COMPANY OVERVIEW 392 TABLE 408 ALS: SERVICES OFFERED 393 TABLE 409 ALS: DEALS, JANUARY 2021–JUNE 2025 394 TABLE 410 FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW 395 TABLE 411 FRONTAGE LABORATORIES, INC.: SERVICES OFFERED 396 TABLE 412 FRONTAGE LABORATORIES, INC.: DEALS, JANUARY 2021–JUNE 2025 398 TABLE 413 FRONTAGE LABORATORIES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 398 TABLE 414 STERIS: COMPANY OVERVIEW 399 TABLE 415 STERIS PLC: SERVICES OFFERED 400 TABLE 416 STERIS PLC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 401 TABLE 417 STERIS PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 401 TABLE 418 STERIS PLC: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 402 TABLE 419 ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW 403 TABLE 420 ELEMENT MATERIALS TECHNOLOGY: SERVICES OFFERED 403 TABLE 421 ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 404 TABLE 422 ELEMENT MATERIALS TECHNOLOGY: DEALS, JANUARY 2021–JUNE 2025 404 TABLE 423 ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS, JANUARY 2021–JUNE 2025 405 TABLE 424 ELEMENT MATERIALS TECHNOLOGY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 406 TABLE 425 PACE ANALYTICAL SERVICES: COMPANY OVERVIEW 407 TABLE 426 PACE ANALYTICAL SERVICES: SERVICES OFFERED 407 TABLE 427 PACE ANALYTICAL SERVICES: DEALS, JANUARY 2021–JUNE 2025 409 TABLE 428 PACE ANALYTICAL SERVICES: EXPANSIONS, JANUARY 2021–JUNE 2025 411 TABLE 429 ALMAC GROUP: COMPANY OVERVIEW 412 TABLE 430 ALMAC GROUP: SERVICES OFFERED 412 TABLE 431 ALMAC GROUP: SERVICE APPROVALS, JANUARY 2021–JUNE 2025 413 TABLE 432 ALMAC GROUP: DEALS, JANUARY 2021–JUNE 2025 413 TABLE 433 ALMAC GROUP: EXPANSIONS, JANUARY 2021–JUNE 2025 413 TABLE 434 PHARMARON BEIJING CO., LTD.: COMPANY OVERVIEW 415 TABLE 435 PHARMARON BEIJING CO., LTD.: SERVICES OFFERED 415 TABLE 436 PHARMARON BEIJING CO., LTD.: DEALS, JANUARY 2021–JUNE 2025 416 TABLE 437 SYNEOS HEALTH: COMPANY OVERVIEW 417 TABLE 438 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 418 TABLE 439 LGC LIMITED: COMPANY OVERVIEW 419 TABLE 440 CELERION: COMPANY OVERVIEW 420 TABLE 441 BIOAGILYTIX: COMPANY OVERVIEW 421 TABLE 442 ALCAMI CORPORATION: COMPANY OVERVIEW 422 TABLE 443 SAMSUNG BIOLOGICS: COMPANY OVERVIEW 423 TABLE 444 CURIA GLOBAL, INC.: COMPANY OVERVIEW 424 TABLE 445 BA SCIENCES: COMPANY OVERVIEW 425 TABLE 446 AVANCE BIOSCIENCES: COMPANY OVERVIEW 426 FIGURE 1 MARKET & GEOGRAPHIC SEGMENTATION 39 FIGURE 2 REGIONAL SEGMENTATION 40 FIGURE 3 HEALTHCARE ANALYTICAL TESTING MARKET: RESEARCH METHODOLOGY 44 FIGURE 4 RESEARCH DESIGN 45 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 50 FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 51 FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52 FIGURE 9 REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION 53 FIGURE 10 TOP-DOWN APPROACH 53 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 12 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CAGR PROJECTIONS, 2025─2030 56 FIGURE 13 DATA TRIANGULATION METHODOLOGY 58 FIGURE 14 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 61 FIGURE 15 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 62 FIGURE 16 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 63 FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 64 FIGURE 18 GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 65 FIGURE 19 RISING NUMBER OF CLINICAL TRIALS AND GROWING OUTSOURCING OF PHARMA R&D SERVICES TO CROS TO PROPEL MARKET 66 FIGURE 20 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2O24 67 FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 68 FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD 69 FIGURE 23 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70 FIGURE 24 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004–2024) 74 FIGURE 25 PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF 2024) 74 FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002–2024 75 FIGURE 27 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS 81 FIGURE 28 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: VALUE CHAIN ANALYSIS 89 FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 91 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE ANALYTICAL TESTING SERVICES 93 FIGURE 31 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY END USER 94 FIGURE 32 REVENUE SHIFT IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 99 FIGURE 33 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 100 FIGURE 34 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 100 FIGURE 35 VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 101 FIGURE 36 USE OF GEN AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 103 FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 177 FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT 237 FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, 2020−2024 313 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2024) 314 FIGURE 41 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 317 FIGURE 42 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY FOOTPRINT 318 FIGURE 43 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 323 FIGURE 44 EV/EBITDA OF KEY VENDORS 327 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 327 FIGURE 46 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS 328 FIGURE 47 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2024) 334 FIGURE 48 LABCORP HOLDINGS INC.: COMPANY SNAPSHOT (2024) 340 FIGURE 49 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024) 345 FIGURE 50 ICON PLC: COMPANY SNAPSHOT (2024) 351 FIGURE 51 IQVIA INC.: COMPANY SNAPSHOT (2024) 356 FIGURE 52 WUXI APPTEC CO., LTD.: COMPANY SNAPSHOT (2024) 360 FIGURE 53 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 364 FIGURE 54 SGS SA: COMPANY SNAPSHOT (2024) 369 FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 375 FIGURE 56 MEDPACE HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 379 FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024) 382 FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024) 385 FIGURE 59 ALS: COMPANY SNAPSHOT (2024) 393 FIGURE 60 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 396 FIGURE 61 STERIS PLC: COMPANY SNAPSHOT (2024) 400